secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORTHWEST BIOTHERAPEUTICS INC (NWBO)
CIK:        0001072379
Form:       8-K
Filed at:   2025-10-31T23:59:59+00:00
Accession:  0001104659-25-104812
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

NW Biotherapeutics enters $5.5M loan agreement with Streeterville Capital
-------------------------------------------------------------------------

- Loan amount $5,505,000; maturity 22 months; interest 8% p.a.; 10% original issue discount.
- No payments for first 8 months; 14 equal monthly installments start June 2026 at 110% pro rata principal plus interest.
- Prepayment allowed with 10% charge; funds used for ongoing business operations.
- Loan includes customary default provisions and potential acceleration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1072379/000110465925104812/0001104659-25-104812-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1072379/000110465925104812/tm2529815d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-104812

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer